Ratnam et al. highlighted the interaction between NF-κB and GDF-15 by showing that constitutive activation of NF-κB in pancreatic cancer cells leads to secretion of GDF-15, a known NF-κB inhibitor, and induces a decreased cytotoxic capacity in TAMs [66]. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.